Current treatments for acute myelogenous leukemia (AML) have not proven very effective, particularly when patients are elderly or already infirm. This collection of articles addresses new and promisin
This volume contains a multitude of chapters from pioneers in the area of genetic mechanisms, targeted therapy, biology and mouse models for acute myelogenous leukemia. AML is the most common form of
